Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BENZONATATE USP, with a corresponding US DMF Number 21703.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2014, and payment made on May 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II